Motley Fool Long-term investing & stock picks

Why Viking Therapeutics Stock Skyrocketed on Tuesday

By newsfeedback@fool.com (Joe Tenebruso)

Read original article on Motley Fool

Shares of Viking Therapeutics (NASDAQ: VKTX) surged on Tuesday after the biopharmaceutical specialist announced encouraging clinical trial results for its experimental weight loss drug.

Image source: Getty Images.

People receiving weekly doses of Viking's investigational obesity drug, VK2735, lost 16% to 19% of their bodyweight after 21 weeks, compared with roughly 0% for placebo.

Continue reading

This story was originally published on Motley Fool. DennTech aggregates headlines from top crypto publications to keep traders informed.

Read full article on Motley Fool

Free Tools

Make better decisions with the right data

📊
Risk & Position Size Calculator
Never risk more than you plan to
 ⚡
Liquidation Price Calculator
Know your number before you trade
 📈
DCA Investment Planner
Model your accumulation strategy
 🎯
SL / TP Calculator
Set precise stop-loss & take-profit levels
Back to Stock Pulse